Tecan Group

Acquisition of Paramit

ANALYST & MEDIA CONFERENCE CALL

JUNE 24, 2021

Speakers

Dr. Achim von Leoprechting, CEO Tania Micki, CFO

Acquisition of Paramit Corporation

TECAN TO EXPAND COMMERCIAL REACH, CAPABILITIES AND GEOGRAPHIC FOOTPRINT

  • Paramit Corporation, a leading OEM developer and manufacturer of medical devices and life sciences instruments
  • Adds complementary expertise, broadens design, development and manufacturing capabilities
  • Expansion into the attractive and fast-growing medical device market segment, close to Tecan's own core competencies
  • Significantly strengthens geographic footprint in the US, the largest life sciences and healthcare market in the world
  • Adds significant engineering as well as cost-competitive manufacturing capabilities, both in US and in the APAC region
  • Total consideration of USD 1.0 billion (CHF 920 million)
  • In full year 2021, Paramit is expected to generate around USD 280m in sales (CHF 257m) and around USD 50m EBITDA (CHF 46m), before acquisition-related costs

3

Acquisition Significantly Expands Total Addressable Market

ADDING A 4TH AND 5TH STRATEGIC GROWTH VECTOR

LIFE SCIENCE RESEARCH

IN-VITRO DIAGNOSTICS

MEDICAL DEVICES

(MEDICAL MECHATRONICS)

>55 BN USD

>60 BN USD

>100 BN USD

(TAM: 4-5 BN)

(TAM: 4 BN)

(TAM: 13-15 BN)

Life Sciences

Partnering

Business

Business

4 Paramit

Implants & Consumables

+ Instruments

Outsourced part of market (TAM)

Partnering Business

5

Paramit

4

Adjacent OEM Offerings for Components and Instrumentation

CLOSE TO TECAN'S OWN CORE COMPETENCIES: 75% OF SALES BASED ON ROBOTICS AND LIQUID HANDLING

LIFE SCIENCE RESEARCH

IN-VITRO DIAGNOSTICS

>55 BN USD

>60 BN USD

(TAM: 4-5 BN)

(TAM: 4 BN)

OEM

Robotic components (e.g. pumps)

Platform-based automation systems

Offering

Dedicated automation systems

Key

NGS, cell biology,

MDx, transfusion medicine,

biopharma manufacturing,

tissue pathology, immuno-

Applications

flow cytometry (…)

assays, NIPT (…)

OEM

Components, modules and systems, based on

Offering

robotic, micro fluidics and optical technologies

Key

NGS, other genomics,

MDx, digital pathology

biomarker detection,

Applications

cell biology, EM (…)

MEDICAL DEVICES

(MEDICAL MECHATRONICS)

>100 BN USD

(TAM: 13-15 BN)

  • Components, modules and systems, based on robotic, micro fluidics, optical, laser and radio frequency technologies
  • Surgical robotics, cardiovascular controllers, reconstructive surgery, laser treatments, hemodialysis (…)

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Tecan Group AG published this content on 24 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 June 2021 15:51:08 UTC.